Last episode, Jane and colleagues unraveled the intricacies of the human microbiome. This week, Jane chats with Mary Keir, Senior Scientist, Biomarker Discovery OMNI, to learn what happens during inflammatory bowel disease (IBD), what causes it, and how targeting dysfunction in our immune system, the gut epithelial barrier and our microbiome could reduce inflammation in the gut.

SUBSCRIBE BELOW TO CATCH EACH EPISODE

If you want to learn more about the groundbreaking science happening in our labs, click here. To learn more about the jobs in our research and early development group, click here.